The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Hans-Joachim Anders

Medical Clinic and Policlinic IV

Nephrological Center

University of Munich

Munich 80336

Germany

[email]@med.uni-muenchen.de

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Medical Clinic and Policlinic IV, Nephrological Center, University of Munich, Munich 80336, Germany. 2013
  • Nephrologisches Zentrum, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Ziemssenstrasse 1, Germany. 2004 - 2012
  • Medical Clinic and Policlinic IV, Nephrological Center, University of Munich, Munich 80336, Germany; E-Mails: (H.E.S.); (C.R.); regina.grö (R.G.); roman.gü (R.G.); (H.-J.A.). 2012
  • Correspondence and offprint requests to: Hans-Joachim Anders; E-mail:. 2012
  • Department of Nephrology, Medizinische Poliklinik, University of Munich, Munich, Germany. 2011
  • Medical Policlinic, University of Munich, Germany. 2006 - 2009
  • Nephrological Center, Medical Policlinic, Ludwig-Maximilians-University Munich, Germany. 2004 - 2007

References

  1. Toll-like receptor and accessory molecule mRNA expression in humans and mice as well as in murine autoimmunity, transient inflammation, and progressive fibrosis. Ramaiah, S.K., Günthner, R., Lech, M., Anders, H.J. Int. J. Mol. Sci (2013) [Pubmed]
  2. Lupus nephritis: Implications of the new ACR lupus nephritis guidelines. Anders, H.J., Appel, G.B. Nat. Rev. Nephrol (2012) [Pubmed]
  3. Quantitative expression of C-type lectin receptors in humans and mice. Lech, M., Susanti, H.E., Römmele, C., Gröbmayr, R., Günthner, R., Anders, H.J. Int. J. Mol. Sci (2012) [Pubmed]
  4. Four danger response programs determine glomerular and tubulointerstitial kidney pathology: clotting, inflammation, epithelial and mesenchymal healing. Anders, H.J. Organogenesis (2012) [Pubmed]
  5. Uromodulin Triggers IL-1β-Dependent Innate Immunity via the NLRP3 Inflammasome. Darisipudi, M.N., Thomasova, D., Mulay, S.R., Brech, D., Noessner, E., Liapis, H., Anders, H.J. J. Am. Soc. Nephrol. (2012) [Pubmed]
  6. Histones from Dying Renal Cells Aggravate Kidney Injury via TLR2 and TLR4. Allam, R., Scherbaum, C.R., Darisipudi, M.N., Mulay, S.R., Hägele, H., Lichtnekert, J., Hagemann, J.H., Rupanagudi, K.V., Ryu, M., Schwarzenberger, C., Hohenstein, B., Hugo, C., Uhl, B., Reichel, C.A., Krombach, F., Monestier, M., Liapis, H., Moreth, K., Schaefer, L., Anders, H.J. J. Am. Soc. Nephrol. (2012) [Pubmed]
  7. Recombinant chaperonin 10 suppresses cutaneous lupus and lupus nephritis in MRL-(Fas)lpr mice. Kulkarni, O.P., Ryu, M., Kantner, C., Sárdy, M., Naylor, D., Lambert, D., Brown, R., Anders, H.J. Nephrol. Dial. Transplant. (2012) [Pubmed]
  8. Pigmented villonodular synovitis of the hip in systemic lupus erythematosus: a case report. Anders, H.J. J. Med. Case. Reports (2011) [Pubmed]
  9. IRF4 Deficiency Abrogates Lupus Nephritis Despite Enhancing Systemic Cytokine Production. Lech, M., Weidenbusch, M., Kulkarni, O.P., Ryu, M., Darisipudi, M.N., Susanti, H.E., Mittruecker, H.W., Mak, T.W., Anders, H.J. J. Am. Soc. Nephrol. (2011) [Pubmed]
  10. Interleukin-1 receptor-associated kinase-M suppresses systemic lupus erythematosus. Lech, M., Kantner, C., Kulkarni, O.P., Ryu, M., Vlasova, E., Heesemann, J., Anz, D., Endres, S., Kobayashi, K.S., Flavell, R.A., Martin, J., Anders, H.J. Ann. Rheum. Dis. (2011) [Pubmed]
  11. Mdm2 promotes systemic lupus erythematosus and lupus nephritis. Allam, R., Sayyed, S.G., Kulkarni, O.P., Lichtnekert, J., Anders, H.J. J. Am. Soc. Nephrol. (2011) [Pubmed]
  12. Pseudoviral immunity - a novel concept for lupus. Anders, H.J. Trends. Mol. Med (2009) [Pubmed]
  13. Predicting thrombosis in systemic lupus erythematosus. Anders, H.J. Nature Clinical Practice. Nephrology (2009) [Pubmed]
  14. Molecular mimicry in innate immunity? The viral RNA recognition receptor TLR7 accelerates murine lupus. Anders, H.J., Krug, A., Pawar, R.D. Eur. J. Immunol. (2008) [Pubmed]
  15. Identifying and validating novel targets with in vivo disease models: guidelines for study design. Anders, H.J., Vielhauer, V. Drug Discov. Today (2007) [Pubmed]
  16. Innate pathogen recognition in the kidney: toll-like receptors, NOD-like receptors, and RIG-like helicases. Anders, H.J. Kidney Int. (2007) [Pubmed]
  17. Progression of kidney disease: blocking leukocyte recruitment with chemokine receptor CCR1 antagonists. Anders, H.J., Ninichuk, V., Schlöndorff, D. Kidney Int. (2006) [Pubmed]
  18. Nucleic acids modulate autoimmunity through nucleic-acid-specific toll-like receptors. Patole, P.S., Anders, H.J. Curr. Med. Chem. (2006) [Pubmed]
  19. A Toll for lupus. Anders, H.J. Lupus (2005) [Pubmed]
  20. Molecular mechanisms of autoimmunity triggered by microbial infection. Anders, H.J., Zecher, D., Pawar, R.D., Patole, P.S. Arthritis Res. Ther. (2005) [Pubmed]
  21. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice. Anders, H.J., Vielhauer, V., Eis, V., Linde, Y., Kretzler, M., Perez de Lema, G., Strutz, F., Bauer, S., Rutz, M., Wagner, H., Gröne, H.J., Schlöndorff, D. FASEB J. (2004) [Pubmed]
  22. Signaling danger: toll-like receptors and their potential roles in kidney disease. Anders, H.J., Banas, B., Schlöndorff, D. J. Am. Soc. Nephrol. (2004) [Pubmed]
  23. Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice. Anders, H.J., Belemezova, E., Eis, V., Segerer, S., Vielhauer, V., Perez de Lema, G., Kretzler, M., Cohen, C.D., Frink, M., Horuk, R., Hudkins, K.L., Alpers, C.E., Mampaso, F., Schlöndorff, D. J. Am. Soc. Nephrol. (2004) [Pubmed]
  24. Current paradigms about chemokines as therapeutic targets. Anders, H.J., Vielhauer, V., Schlöndorff, D. Nephrol. Dial. Transplant. (2004) [Pubmed]
 
WikiGenes - Universities